Black Rock Inc. Liquidia Corp Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Liquidia Corp stock. As of the latest transaction made, Black Rock Inc. holds 4,240,740 shares of LQDA stock, worth $48.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,240,740
Previous 3,747,491
13.16%
Holding current value
$48.9 Million
Previous $55.3 Million
7.94%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LQDA
# of Institutions
171Shares Held
44.3MCall Options Held
1.55MPut Options Held
1.52M-
Patient Square Capital LP Menlo Park, CA7.18MShares$82.8 Million26.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$39.7 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$37.9 Million0.17% of portfolio
-
Findell Capital Management LLC New York, NY3.19MShares$36.8 Million16.08% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.27MShares$26.1 Million1.86% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $742M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...